You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 16, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Maria De Carluccio1, Gabriele Di Sante2, Maria Elisabetta Clementi3
1Department of Neuroscience, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
S100B protein, particularly from astrocytes, drives neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). Reducing S100B levels ameliorates disease symptoms and pathology, identifying it as a therapeutic target.
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: